Eevia Health Plc receives a 511 KSEK/43,3 KEUR sales order for a Pine bark extract product
Eevia Health Plc, (”Eevia” or ”The Company”), has received a 43,3 KEUR sales order from the US for Fenoprolic 70 Organic, an organically certified pine bark extract
The end customer is a large supplement brand holder which operates in several channels in North America and in Europe. The immediate customer is Barrington Nutritionals, a US distributor.
The sales value to Eevia of this new order is c. 43,3 kEUR. The product is Eevia’s branded ingredient Fenoprolic® 70 Organic, which is a highly concentrated and organically certified pine bark extract.
The product contains 70% oligomeric proanthocyanidins and offers clinical benefits for people with osteoarthritis and chronic inflammation. It is extracted and standardized from bark originating from the Pinus Sylvestris pine trees that are abundant in Finland and Sweden.
“Eevia is particularly happy to receive orders for the Fenoprolic® 70 Organic, because it is the product with best profitability of our product lines and there are significant sales opportunities for this product.” states Stein Ulve, CEO.
The order is expected to be followed by further repeat orders in the future.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: stein.ulve@eeviahealth.com
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.
